Skip to main content
MedPathMedPath Home
Clinical Trials/2025-524852-74-00
2025-524852-74-00
Recruiting
Phase 1

A clinical trial of MK-3214 taken with different liquids in healthy participants (MK-3214-002)

Merck Sharp & Dohme LLC1 site in 1 country32 target enrollmentStarted: March 17, 2026Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 1
Status
Recruiting
Enrollment
32
Locations
1
OverviewEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Overview

Brief Summary

No summary available.

Eligibility Criteria

Ages
18 years to 64 years (18-64 Years)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Investigators

Sponsor Class
Pharmaceutical company
Responsible Party
Principal Investigator
Principal Investigator

Doug Johns

Scientific

Merck Sharp & Dohme LLC

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 1
A clinical study of MK-2828 in healthy people (MK-2828-001)
2024-513377-51-00Merck Sharp & Dohme LLC16
Not yet recruiting
Phase 1/2
A Clinical study of MK-4716 in people with certain solid tumors (MK-4716-001)
2025-522495-84-00Merck Sharp & Dohme LLC29
Recruiting
Phase 1
A clinical trial of MK-6916 in healthy participants (MK-6916-010)
2025-524570-41-00Merck Sharp & Dohme LLC54
Completed
Phase 1
A clinical study of MK-1403 in healthy men
2023-504695-23-00Merck Sharp & Dohme LLC24
Recruiting
Phase 1
A clinical study of MK-6916 in healthy people (MK-6916-006)
2025-521487-36-00Merck Sharp & Dohme LLC40